Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies

Posaconazole (PCZ), approved for prophylaxis against invasive fungal disease in high-risk patients, is commercially available orally as a suspension formulation (PCZ-susp) and as a delayed-release tablet (PCZ-tab). We evaluated the serum steady-state concentrations (C(ss)) of PCZ stratified by the a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Antimicrob Agents Chemother
Asıl Yazarlar: Cumpston, Aaron, Caddell, Ryan, Shillingburg, Alexandra, Lu, Xiaoxiao, Wen, Sijin, Hamadani, Mehdi, Craig, Michael, Kanate, Abraham S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2015
Konular:
Clinical Therapeutics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4505228/
https://ncbi.nlm.nih.gov/pubmed/25987632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00581-15
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller